(Q30367793)

English

Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

8

object named as

Hualan Chen

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Chunyi Xue

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Guobin Tian

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Xianxian Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Qiliang Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Jun Ma

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Shun Xu

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Xiaoming Li

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Yongchang Cao

9

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

publication date

1 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

195

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

35-42

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Update on avian influenza A (H5N1) virus infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Vaccination against Newcastle disease: efficacy of an oil emulsion vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Emerging respiratory viruses: challenges and vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

CD4+ and CD8+ mediated cellular immune response to recombinant influenza nucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Influenza virus-like particle vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Pandemic Threat Posed by Avian Influenza A Viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Influenza vaccines based on virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Induction of long-term protective immune responses by influenza H5N1 virus-like particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Virus-like particles as immunogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Vaccines developed for H5 highly pathogenic avian influenza in China.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Protective efficacy of the H5 inactivated vaccine against different highly pathogenic H5N1 avian influenza viruses isolated in China and Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Are we ready for pandemic influenza?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.09.018

7 January 2021

Identifiers

10.1016/J.VIRUSRES.2014.09.018

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30367793&oldid=1639070153"